ResMed / Commercialisation Australia / Australian Securities Exchange / CSL / The Clinical Trials Action Group / Innovation Investment Fund / International Investment Fund / Biotech Fund / Cochlear / AusBiotech Ltd / /
Continent
Asia / /
Country
New Zealand / France / United States / Canada / Australia / United Kingdom / Singapore / /
Currency
AUD / USD / / /
Event
Environmental Issue / /
Facility
Chapel St South Yarra VIC / /
IndustryTerm
venture capital / eligible start-up / biotechnology / high-tech manufacturing / biotechnology achievement / industrial and agricultural biotechnology sectors / technology development / start-up / finance / pre-revenue technology / food technology / medical technology / technology community / manufacturing sector / food production / venture capital funds / biotechnology industry / Biotechnology-based products / trials liability insurance scheme / venture capital sector / mining / manufacturing / home-grown technologies / car manufacturing / technology-based products / workable solution / biotechnology sector / /
Movie
Around the world / /
Organization
Federal Government Budget Policy Division Department of the Treasury Langton Crescent PARKES ACT / Reserve Bank of Australia / Medical Research Future Fund / Federal Government / African Union / Medical Technology Association of Australia / Export Council of Australia / Translational Biotech Fund / / /
Position
Governor / representative / /
PublishedMedium
the McKeon Review / the Strategic Review / the Cutler Innovation Review / /
AusBiotech’s pre-Budget submission to the Federal Government Budget Policy Division Department of the Treasury Langton Crescent